Wechselwirkungen · Cholib
Cholib 145 mg/40 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 32
HOS-127062 · Präparat HOS-096355
Interacting substances Prescribing recommendations Potent CYP 3A4 inhibitors: Itraconazole Ketoconazole Fluconazole Posaconazole Erythromycin Contraindicated with Cholib Clarithromycin Telithromycin HIV protease inhibitors (e.g. nelfinavir) Nefazodone Cobicistat Danazol Contraindicated with Cholib Ciclosporin Gemfibrozil, Other statins and fibrates Contraindicated with Cholib Amiodarone Verapamil Contraindicated with Cholib 145 mg/40 mg Diltiazem Amlodipine Elbasvir Contraindicated with Cholib 145 mg/40 mg Grazoprevir Glecaprevir Contraindicated with Cholib Pibrentasvir Avoid with Cholib unless clinical benefit outweigh the risk Niacin (nicotinic acid) ≥ 1 g/day Monitor patients for any signs and symptoms of muscle pain, tenderness or weakness Patients should be closely monitored. Fusidic acid Temporary suspension of Cholib treatment may be considered Grapefruit juice Avoid when taking Cholib Adjust the dose of these oral anticoagulants Vitamin K antagonists according to INR monitoring Monitor HDL-C and stop either therapy Glitazones (glitazone or Cholib) if HDL-C is too low
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): diltiazem (HOS-086288) nefazodone (HOS-084519) elbasvir (HOS-108814) nelfinavir (HOS-084520) protease (HOS-085623) fusidic acid (HOS-086146) ketoconazole (HOS-084513) pibrentasvir (HOS-086298) cobicistat (HOS-088111) vitamin K (HOS-091176) amlodipine (HOS-086287) gemfibrozil (HOS-088403) glecaprevir (HOS-086297) grapefruit juice (HOS-088787) niacin (HOS-126975) telithromycin (HOS-084523) grazoprevir (HOS-108815) itraconazole (HOS-084516) danazol (HOS-085473) fluconazole (HOS-087945) clarithromycin (HOS-084517) erythromycin (HOS-084514) amiodarone (HOS-085596) posaconazole (HOS-085622) verapamil (HOS-090602)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-06T10:28:00Z · SHA-256 348750d8a2030faed77c9c061fe6342a446d1448175630ef5f5390d9ff5afaad · Passage 6d5c5fec1da2b5e3bb3b7b5c49df8bee2d9cf49df82aef774324124447b7a727 · Zeichen 10741–12812 im Abschnitt